pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity

Experimental autoimmune encephalomyelitis (EAE) is a demyelinating pathology of the central nervous system (CNS) used as a model to study multiple sclerosis immunopathology. EAE has also been extensively employed to evaluate potentially therapeutic schemes. Considering the presence of an immune resp...

Full description

Saved in:
Bibliographic Details
Main Authors: Sofia Fernanda Gonçalves Zorzella-Pezavento, Fernanda Chiuso-Minicucci, Thais Graziela Donegá França, Larissa Lumi Watanabe Ishikawa, Larissa Camargo da Rosa, Priscila Maria Colavite, Bianca Balbino, Camila Marques, Maura Rosane Valerio Ikoma, Ana Paula Masson, Célio Lopes Silva, Alexandrina Sartori
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2017/6257958
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832564422498844672
author Sofia Fernanda Gonçalves Zorzella-Pezavento
Fernanda Chiuso-Minicucci
Thais Graziela Donegá França
Larissa Lumi Watanabe Ishikawa
Larissa Camargo da Rosa
Priscila Maria Colavite
Bianca Balbino
Camila Marques
Maura Rosane Valerio Ikoma
Ana Paula Masson
Célio Lopes Silva
Alexandrina Sartori
author_facet Sofia Fernanda Gonçalves Zorzella-Pezavento
Fernanda Chiuso-Minicucci
Thais Graziela Donegá França
Larissa Lumi Watanabe Ishikawa
Larissa Camargo da Rosa
Priscila Maria Colavite
Bianca Balbino
Camila Marques
Maura Rosane Valerio Ikoma
Ana Paula Masson
Célio Lopes Silva
Alexandrina Sartori
author_sort Sofia Fernanda Gonçalves Zorzella-Pezavento
collection DOAJ
description Experimental autoimmune encephalomyelitis (EAE) is a demyelinating pathology of the central nervous system (CNS) used as a model to study multiple sclerosis immunopathology. EAE has also been extensively employed to evaluate potentially therapeutic schemes. Considering the presence of an immune response directed to heat shock proteins (hsps) in autoimmune diseases and the immunoregulatory potential of these molecules, we evaluated the effect of a previous immunization with a genetic vaccine containing the mycobacterial hsp65 gene on EAE development. C57BL/6 mice were immunized with 4 pVAXhsp65 doses and 14 days later were submitted to EAE induction by immunization with myelin oligodendrocyte glycoprotein (MOG35–55) emulsified in Complete Freund’s Adjuvant. Vaccinated mice presented significant lower clinical scores and lost less body weight. MOG35–55 immunization also determined less inflammation in lumbar spinal cord but did not change CD4+CD25+Foxp3+ T cells frequency in spleen and CNS. Infiltrating cells from the CNS stimulated with rhsp65 produced significantly higher levels of IL-10. These results suggest that the ability of pVAXhsp65 vaccination to control EAE development is associated with IL-10 induction.
format Article
id doaj-art-abccc886b45b473290fdb4e811f4296b
institution Kabale University
issn 2314-8861
2314-7156
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-abccc886b45b473290fdb4e811f4296b2025-02-03T01:11:00ZengWileyJournal of Immunology Research2314-88612314-71562017-01-01201710.1155/2017/62579586257958pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis SeveritySofia Fernanda Gonçalves Zorzella-Pezavento0Fernanda Chiuso-Minicucci1Thais Graziela Donegá França2Larissa Lumi Watanabe Ishikawa3Larissa Camargo da Rosa4Priscila Maria Colavite5Bianca Balbino6Camila Marques7Maura Rosane Valerio Ikoma8Ana Paula Masson9Célio Lopes Silva10Alexandrina Sartori11Department of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, BrazilDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, BrazilDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, BrazilDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, BrazilDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, BrazilDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, BrazilDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, BrazilFlow Cytometry Laboratory, Amaral Carvalho Foundation, Jaú, SP, BrazilFlow Cytometry Laboratory, Amaral Carvalho Foundation, Jaú, SP, BrazilDepartment of Biochemistry and Immunology, University of São Paulo (USP), Ribeirão Preto, SP, BrazilDepartment of Biochemistry and Immunology, University of São Paulo (USP), Ribeirão Preto, SP, BrazilDepartment of Microbiology and Immunology, Institute of Biosciences of Botucatu, Universidade Estadual Paulista (UNESP), Botucatu, SP, BrazilExperimental autoimmune encephalomyelitis (EAE) is a demyelinating pathology of the central nervous system (CNS) used as a model to study multiple sclerosis immunopathology. EAE has also been extensively employed to evaluate potentially therapeutic schemes. Considering the presence of an immune response directed to heat shock proteins (hsps) in autoimmune diseases and the immunoregulatory potential of these molecules, we evaluated the effect of a previous immunization with a genetic vaccine containing the mycobacterial hsp65 gene on EAE development. C57BL/6 mice were immunized with 4 pVAXhsp65 doses and 14 days later were submitted to EAE induction by immunization with myelin oligodendrocyte glycoprotein (MOG35–55) emulsified in Complete Freund’s Adjuvant. Vaccinated mice presented significant lower clinical scores and lost less body weight. MOG35–55 immunization also determined less inflammation in lumbar spinal cord but did not change CD4+CD25+Foxp3+ T cells frequency in spleen and CNS. Infiltrating cells from the CNS stimulated with rhsp65 produced significantly higher levels of IL-10. These results suggest that the ability of pVAXhsp65 vaccination to control EAE development is associated with IL-10 induction.http://dx.doi.org/10.1155/2017/6257958
spellingShingle Sofia Fernanda Gonçalves Zorzella-Pezavento
Fernanda Chiuso-Minicucci
Thais Graziela Donegá França
Larissa Lumi Watanabe Ishikawa
Larissa Camargo da Rosa
Priscila Maria Colavite
Bianca Balbino
Camila Marques
Maura Rosane Valerio Ikoma
Ana Paula Masson
Célio Lopes Silva
Alexandrina Sartori
pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity
Journal of Immunology Research
title pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity
title_full pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity
title_fullStr pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity
title_full_unstemmed pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity
title_short pVAXhsp65 Vaccination Primes for High IL-10 Production and Decreases Experimental Encephalomyelitis Severity
title_sort pvaxhsp65 vaccination primes for high il 10 production and decreases experimental encephalomyelitis severity
url http://dx.doi.org/10.1155/2017/6257958
work_keys_str_mv AT sofiafernandagoncalveszorzellapezavento pvaxhsp65vaccinationprimesforhighil10productionanddecreasesexperimentalencephalomyelitisseverity
AT fernandachiusominicucci pvaxhsp65vaccinationprimesforhighil10productionanddecreasesexperimentalencephalomyelitisseverity
AT thaisgrazieladonegafranca pvaxhsp65vaccinationprimesforhighil10productionanddecreasesexperimentalencephalomyelitisseverity
AT larissalumiwatanabeishikawa pvaxhsp65vaccinationprimesforhighil10productionanddecreasesexperimentalencephalomyelitisseverity
AT larissacamargodarosa pvaxhsp65vaccinationprimesforhighil10productionanddecreasesexperimentalencephalomyelitisseverity
AT priscilamariacolavite pvaxhsp65vaccinationprimesforhighil10productionanddecreasesexperimentalencephalomyelitisseverity
AT biancabalbino pvaxhsp65vaccinationprimesforhighil10productionanddecreasesexperimentalencephalomyelitisseverity
AT camilamarques pvaxhsp65vaccinationprimesforhighil10productionanddecreasesexperimentalencephalomyelitisseverity
AT maurarosanevalerioikoma pvaxhsp65vaccinationprimesforhighil10productionanddecreasesexperimentalencephalomyelitisseverity
AT anapaulamasson pvaxhsp65vaccinationprimesforhighil10productionanddecreasesexperimentalencephalomyelitisseverity
AT celiolopessilva pvaxhsp65vaccinationprimesforhighil10productionanddecreasesexperimentalencephalomyelitisseverity
AT alexandrinasartori pvaxhsp65vaccinationprimesforhighil10productionanddecreasesexperimentalencephalomyelitisseverity